[Antiplatelet drugs (author's transl)].
作者信息
Dechavanne M, Follea G, Trzeciak M C
出版信息
Anesth Analg (Paris). 1979;36(7-8):283-7.
PMID:525834
Abstract
Acetyl salicylic acid, sulfinpyrazone, dipyridamole, hydroxychloroquine, ticlopidine, clofibrate, nicergoline are the most used antiplatelet drugs. A. S. A. and sulfinpyrazone have been tested in several large scale clinical trials. A. S. A. seems beneficial in the prevention of cerebral ischemia for patients, specially men who have previously had a transient cerebral ischemic attack. Sulfinpyrazone appears to be effective in reducing cardiac deaths during the first year after myocardial infarction.
摘要
相似文献
1
[Antiplatelet drugs (author's transl)].
Anesth Analg (Paris). 1979;36(7-8):283-7.
2
Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells.
Prog Clin Biol Res. 1982;89:31-62.
3
[Role of antiplatelet agents in the prevention of cerebral ischemic accidents].
J Mal Vasc. 1983;8(1):17-22.
4
[Action mechanism and clinical indications for thrombocyte aggregation inhibitors].[血小板聚集抑制剂的作用机制及临床适应证]
Schweiz Med Wochenschr. 1979 Mar 10;109(10):348-53.
5
Effect of drugs of platelets and complications of vascular disease.
Adv Exp Med Biol. 1977;82:94-105. doi: 10.1007/978-1-4613-4220-5_9.
6
Aspirin and other platelet-aggregation inhibiting drugs.阿司匹林及其他血小板聚集抑制药物。
Med J Aust. 1985 Jan 7;142(1):41-7.
7
Status of antiplatelet drugs in coronary heart disease.
JAMA. 1979 Jun 15;241(24):2649-51.
8
Antiplatelet drugs-a new pharmacologic approach to the prevention of thrombosis.
Am Heart J. 1976 Jul;92(1):86-102. doi: 10.1016/s0002-8703(76)80408-5.
9
Is the antithrombotic activity of "antiplatelet" drugs based on protection of endothelium?
Thromb Haemost. 1979 Jun 30;41(4):474-8.
10
Pharmacology of antiplatelet drugs and clinical trials on thrombosis prevention: a difficult link.
Lancet. 1982 Oct 30;2(8305):974-7. doi: 10.1016/s0140-6736(82)90168-4.
Zotero 插件